AWHAspira Women's Health Inc.

Nasdaq aspirawh.com


$ 3.51 $ 0.04 (1.15 %)    

Thursday, 18-Apr-2024 15:57:32 EDT
QQQ $ 414.59 $ -8.60 (-2.03 %)
DIA $ 379.83 $ 1.96 (0.52 %)
SPY $ 494.96 $ -4.47 (-0.9 %)
TLT $ 89.15 $ 0.32 (0.36 %)
GLD $ 221.02 $ 0.67 (0.3 %)
$ 3.49
$ 3.48
$ 0.00 x 0
$ 0.00 x 0
$ 3.48 - $ 3.51
$ 2.31 - $ 6.75
7,831
na
32.59M
$ 1.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-29-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-30-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-10-2022 06-30-2022 10-Q
8 05-11-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
13 03-31-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 05-14-2020 03-31-2020 10-Q
17 04-07-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-08-2019 06-30-2019 10-Q
20 05-14-2019 03-31-2019 10-Q
21 03-28-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-14-2018 03-31-2018 10-Q
25 03-13-2018 12-31-2017 10-K
26 11-08-2017 09-30-2017 10-Q
27 08-11-2017 06-30-2017 10-Q
28 05-11-2017 03-31-2017 10-Q
29 03-31-2017 12-31-2016 10-K
30 11-10-2016 09-30-2016 10-Q
31 08-10-2016 06-30-2016 10-Q
32 05-16-2016 03-31-2016 10-Q
33 03-30-2016 12-31-2015 10-K
34 11-12-2015 09-30-2015 10-Q
35 08-13-2015 06-30-2015 10-Q
36 05-12-2015 03-31-2015 10-Q
37 03-31-2015 12-31-2014 10-K
38 11-13-2014 09-30-2014 10-Q
39 08-14-2014 06-30-2014 10-Q
40 05-15-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cantor-fitzgerald-reiterates-neutral-on-aspira-womens-health-maintains-33-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates Aspira Womens Health (NASDAQ:AWH) with a Neutral and maintains $3.3 price t...

 cantor-fitzgerald-maintains-neutral-on-aspira-womens-health-lowers-price-target-to-33

Cantor Fitzgerald analyst Ross Osborn maintains Aspira Womens Health (NASDAQ:AWH) with a Neutral and lowers the price target...

 aspira-womens-health-q4-eps-030-beats-045-estimate-sales-213m-miss-254m-estimate

Aspira Womens Health (NASDAQ:AWH) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $...

 earnings-scheduled-for-march-28-2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

 first-lady-jill-biden-unveils-100m-in-federal-funding-to-support-rd---watch-out-for-these-women-health-stocks

Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of aware...

 aspira-womens-health-announces-late-breaking-poster-presentation-at-the-upcoming-71st-annual-scientific-meeting-for-the-society-for-reproductive-investigation

Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on th...

 17m-bet-on-erasca-check-out-these-4-penny-stocks-insiders-are-aggressively-buying

The Dow Jones closed lower by around 70 points on Wednesday. When insiders purchase or sell shares, it indicates their confiden...

 aspira-womens-health-provides-a-development-update-on-its-portfolio-of-noninvasive-tests-for-endometriosis

Data supports EndoCheck™ to be the first blood test for the identification of localized endometriosis, including endometriomaPl...

 aspira-womens-health-q3-eps-048-beats-051-estimate-sales-222m-miss-291m-estimate

Aspira Womens Health (NASDAQ:AWH) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $...

 earnings-scheduled-for-november-13-2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr...

 cantor-fitzgerald-reiterates-neutral-on-aspira-womens-health-maintains-4-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates Aspira Womens Health (NASDAQ:AWH) with a Neutral and maintains $4 price tar...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION